A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy. (Q46411204)
Jump to navigation
Jump to search
scientific article published on 29 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy. |
scientific article published on 29 November 2013 |
Statements
1 reference
A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy (English)
Andy Davies
Sharon Barrans
Lisa Worrillow
Matt Care
Debbie Hamid
Andrew McMillan
Paul Fields
Andrew Jack
29 November 2013
1 reference
1 November 2013
1 reference